Treatment With Naringenin Elevates the Activity of Transcription Factor Nrf2 to Protect Pancreatic β-Cells From Streptozotocin-Induced Diabetes in vitro and in vivo

por Rajappa, Rashmi, Sireesh, Dornadula, Salai, Magesh B., Ramkumar, Kunka M., Sarvajayakesavulu, Suryanarayanan, Madhunapantula, SubbaRao V.
Publicado 2019